Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/25/21
End: 12/10/23
Due: 12/10/24
Phase: N/A
Priority: Normal
Start: 11/12/21
End: 10/31/24
Due: 10/31/25
Phase: N/A
Priority: Normal
Start: 03/10/19
End: 02/20/20
Due: 02/20/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Robot-assisted Invasion-controlled Surgery Versus Traditional-open Surgery Against Metastatic Spinal Tumor | NCT05173467 | Wei Xu | user2@example.com | None | 2021-12-25 | 2023-12-10 | 2024-12-10 | - | - | 2025-07-14 |
| Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary | NCT05241132 | Wei Xu | user2@example.com | None | 2021-11-12 | 2024-10-31 | 2025-10-31 | - | - | 2025-07-14 |
| Characteristics of Gut Microbiota in Patients With Colon Cancer of Different Traditional Chinese Medicine Syndromes | NCT03892252 | Wei Xu | user2@example.com | None | 2019-03-10 | 2020-02-20 | 2021-02-20 | - | - | 2025-07-14 |